FDA Label for Toas Rejuvenation

View Indications, Usage & Precautions

Toas Rejuvenation Product Label

The following document was submitted to the FDA by the labeler of this product Toas Co., Ltd.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Otc - Active Ingredient



Niacinamide 0.5%


Otc - Purpose



Brightening


Indications & Usage



Helps brightness and moisturizing


Dosage & Administration



Apply an appropriate amount and Pat on skin with fingertips, AM and PM.


Warnings



For external use only.
Do not use on damaged or broken skin.
When using this product, keep out of eyes. Rinse with water to remove.
Stop using and ask a doctor if rash occurs.


Otc - Keep Out Of Reach Of Children



Keep out of reach of the children. If product is swallowed, get medical help or contact a poison control center right away.


Inactive Ingredient



Water, Butylene Glycol, Propylene Glycol, Caprylic/Capric Triglyceride, Cetyl Ethylhexanoate, Olea Europaea (Olive) Fruit Oil, 1.2-Hexanediol, Glycerin, Betaine, Cetearyl Alcohol, Macadamia Integrifolia Seed Oil, Vitis Vinifera (Grape) Seed Oil, Beeswax, PEG/PPG-17/6 Copolymer, Polysorbate 60, Butyrospermum Parkii (Shea) Butter, Cyclopentasiloxane, Glyceryl Stearate, Sorbitan Sesquioleate, Glycereth-26, Stearic Acid, Arginine, PEG-100 Stearate, Carbomer, Sodium Hyaluronate, Fragrance, Xanthan Gum, Centella Asiatica Extract, Tocopheryl Acetate, Ethylhexylglycerin, Polygonum Cuspidatum Root Extract, Scutellaria Baicalensis Root Extract, Camellia Sinensis Leaf Extract, Glycyrrhiza Glabra (Licorice) Root Extract, Chamomilla Recutita (Matricaria) Flower Extract, Rosmarinus Officinalis (Rosemary) Leaf Extract, Lecithin, Adenosine, Hydrogenated Lecithin, Oligopeptide-1


* Please review the disclaimer below.